 |
FDA-TRACK is an agency-wide performance management system that monitors FDA programs through key performance measures and projects. These measures are updated quarterly on the website.
What’s New in September 2013
This update was postponed due to the federal government shutdown. Thank you for your patience during this time. New performance data are available for the dashboards below.
Cross Agency
- FDA Safety and Innovation Act (FDASIA)-TRACK: FDA held a 2-day public meeting in July to gather input on issues and challenges associated with the standardization and
- FDA-TRACK Health Care Reform Dashboard: As part of Section 3507 of the Affordable Care Act, FDA completed milestones for the Evaluation of Standardized Risk Benefit Information project, including two research studies on display and format of prescription drug information.
Center for Biologics Evaluation and Research (CBER):
- FDA-TRACK CBER Dashboard: CBER completed its key project, Fecal Microbiome Transplantation Workshop to exchange information with the medical and scientific community on the regulatory and scientific challenges of fecal microbiome transplantation.
Center for Food Safety and Applied Nutrition (CFSAN)
- FDA-TRACK CFSAN Dashboard: The Office of Compliance (OC) completed its Foreign Country Profile Template Key Project to create a profile for every country where a foreign inspection has taken place since 2009. These profiles are aimed to improve risk based decision making by correlating multiple streams of country-specific data and information into a controlled number of indicators.
Office of Regulatory Affairs (ORA)
- FDA-TRACK ORA Dashboard: ORA added interactive maps to its dashboard page to show the breadth of inspections being completed, both by commodity and geographical location. Thus far in FY 2013, ORA completed 26,391 domestic inspections and 1,886 foreign inspections. Check out ORA’s updated dashboard to see where these inspections occurred.
October 2013 Upcoming Performance Data Updates
- Center for Drug Evaluation and Research (CDER)
- Center for Devices and Radiological Health (CDRH)
- Freedom of Information Act (FOIA)
- Medical Countermeasures Initiative (MCMi)
- National Center for Toxicological Research (NCTR)
- Office of the Commissioner (OC) Administrative Offices
- Office of International Programs (OIP)
- Office of the Chief Scientist (OCS)
General Program Updates
- NEW! We updated the FDA-TRACK Index with new features so you can view measures and projects by category (e.g., Food, Drugs, etc.), or by FDA strategic plan and/or strategic goal.
- Most Popular Quarterly Content – Visit this page for FY 2013 Quarter 3 most visited and clicked content.
| This email was sent to kostikblog@ukr.net using GovDelivery, on behalf of: U.S. Food & Drug Administration (FDA) · 10903 New Hampshire Ave · Silver Spring, MD 20993 · 800-439-1420 |  |
